| Immunohistochemical Expression of Claudin-1 and Claudin-4 in Urothelial Carcinoma of the Urinary Bladder. | Immunohistochemical Expression of Claudin-1 and Claudin-4 in Urothelial Carcinoma of the Urinary Bladder.
Elsayed AM, Mahmoud EI, Salem MM, Khairy RA., Free PMC Article | 02/29/2024 |
| Expression of Claudin-4 and D2-40 and their significance in prostatic adenocarcinoma. | Expression of Claudin-4 and D2-40 and their significance in prostatic adenocarcinoma.
Kabra H, Mohanty NR, Tripathy S, Mohanty M, Senapati U, Rath J. | 02/26/2024 |
| Diagnostic Utility of Claudin4 and Comparison with BerEp4 as a Marker for Metastatic Adenocarcinoma in Serous Effusions. | Diagnostic Utility of Claudin4 and Comparison with BerEp4 as a Marker for Metastatic Adenocarcinoma in Serous Effusions.
Mangla G, Bakshi P, Agarwal P, Verma K. | 10/13/2023 |
| [Effects of Fusobacterium nucleus derived outer membrane vesicles on claudin-4 expression in oral epithelial cells]. | [Effects of Fusobacterium nucleus derived outer membrane vesicles on claudin-4 expression in oral epithelial cells].
Yang CL, Yang M, Wang YF, Song CC, DU GH, Tang GY. | 05/12/2023 |
| CLDN4 as a Novel Diagnostic and Prognostic Biomarker and Its Association with Immune Infiltrates in Ovarian Cancer. | CLDN4 as a Novel Diagnostic and Prognostic Biomarker and Its Association with Immune Infiltrates in Ovarian Cancer.
Hu P, Lei L, Wang Y, Tian X, Wei X, Jiang N, Liu L., Free PMC Article | 04/19/2023 |
| BAP1 and Claudin-4, But Not MTAP, Reliably Distinguish Borderline and Low-grade Serous Ovarian Tumors From Peritoneal Mesothelioma. | BAP1 and Claudin-4, But Not MTAP, Reliably Distinguish Borderline and Low-grade Serous Ovarian Tumors From Peritoneal Mesothelioma.
Devins KM, Zukerberg L, Watkins JC, Hung YP, Oliva E. | 02/14/2023 |
| Computational study of ion permeation through claudin-4 paracellular channels. | Computational study of ion permeation through claudin-4 paracellular channels.
Berselli A, Alberini G, Benfenati F, Maragliano L., Free PMC Article | 10/22/2022 |
| CLDN4 promotes growth of acute myeloid leukemia cells via regulating AKT and ERK1/2 signaling. | CLDN4 promotes growth of acute myeloid leukemia cells via regulating AKT and ERK1/2 signaling.
Hao S, Yang C, Song P, Shi H, Zou Y, Chen M, Wu X, Yin Y, Yu Z, Zhu W, Li M. | 07/16/2022 |
| TGF-beta induces GBM mesenchymal transition through upregulation of CLDN4 and nuclear translocation to activate TNF-alpha/NF-kappaB signal pathway. | TGF-β induces GBM mesenchymal transition through upregulation of CLDN4 and nuclear translocation to activate TNF-α/NF-κB signal pathway.
Yan T, Tan Y, Deng G, Sun Z, Liu B, Wang Y, Yuan F, Sun Q, Hu P, Gao L, Tian D, Chen Q., Free PMC Article | 04/30/2022 |
| Increased integrity of cell-cell junctions accompanied by increased expression of claudin 4 in keratinocytes stimulated with vitamin D3. | Increased integrity of cell-cell junctions accompanied by increased expression of claudin 4 in keratinocytes stimulated with vitamin D3.
Minowa E, Kurashige Y, Islam ST, Yoshida K, Sakakibara S, Okada Y, Fujita Y, Bolortsetseg D, Murai Y, Abiko Y, Saitoh M. | 01/22/2022 |
| Association of the Tight Junction Protein Claudin-4 with Lung Function and Exacerbations in Chronic Obstructive Pulmonary Disease. | Association of the Tight Junction Protein Claudin-4 with Lung Function and Exacerbations in Chronic Obstructive Pulmonary Disease.
Park S, Lee PH, Baek AR, Park JS, Lee J, Park SW, Kim DJ, Jang AS., Free PMC Article | 11/27/2021 |
| Structural basis for Clostridium perfringens enterotoxin targeting of claudins at tight junctions in mammalian gut. | Structural basis for Clostridium perfringens enterotoxin targeting of claudins at tight junctions in mammalian gut.
Vecchio AJ, Rathnayake SS, Stroud RM., Free PMC Article | 11/27/2021 |
| Identification of Significant Genes and Pathways in Acute Pancreatitis via Bioinformatical Analysis. | Identification of Significant Genes and Pathways in Acute Pancreatitis via Bioinformatical Analysis.
Ji R, Chen Y, Chen W, Wang Y, Gong F, Huang S, Xie R, Zhong M, Liu Z, Yang Z, Fei J, Mao E, Chen E. | 10/2/2021 |
| The role of claudin-4 in the development of gastric cancer. | The role of claudin-4 in the development of gastric cancer.
Liu W, Li M. | 09/25/2021 |
| CLDN4 silencing promotes proliferation and reduces chemotherapy sensitivity of gastric cancer cells through activation of the PI3K/Akt signalling pathway. | CLDN4 silencing promotes proliferation and reduces chemotherapy sensitivity of gastric cancer cells through activation of the PI3K/Akt signalling pathway.
Luo J, Wang H, Chen H, Gan G, Zheng Y. | 09/11/2021 |
| Comparison of claudin-3 and claudin-4 expression in bilateral and unilateral breast cancer. | Comparison of claudin-3 and claudin-4 expression in bilateral and unilateral breast cancer.
Szade J, Kunc M, Pieczyńska-Uziębło B, Świerblewski M, Biernat W, Jassem J, Senkus E. | 08/21/2021 |
| Screening approaches against claudin-4 focusing on therapeutics through molecular docking and the analysis of their relative dynamics: a theoretical approach. | Screening approaches against claudin-4 focusing on therapeutics through molecular docking and the analysis of their relative dynamics: a theoretical approach.
Rambabu M, Jayanthi S. | 07/17/2021 |
| Knockdown of CRAD suppresses the growth and promotes the apoptosis of human lung cancer cells via Claudin 4. | Knockdown of CRAD suppresses the growth and promotes the apoptosis of human lung cancer cells via Claudin 4.
Cui A, Xue Y, Wang X, Huang Y, Han X, Li X, Niu D, Niu S, Zhao Y, Yang X, Yu W., Free PMC Article | 04/17/2021 |
| Zinc finger protein 703 induces EMT and sorafenib resistance in hepatocellular carcinoma by transactivating CLDN4 expression. | Zinc finger protein 703 induces EMT and sorafenib resistance in hepatocellular carcinoma by transactivating CLDN4 expression.
Wang H, Xu H, Ma F, Zhan M, Yang X, Hua S, Li W, Li Y, Lu L., Free PMC Article | 04/13/2021 |
| All Benign and Malignant Apocrine Breast Lesions Over-Express Claudin 1 and 3 and Are Negative for Claudin 4. | All Benign and Malignant Apocrine Breast Lesions Over-Express Claudin 1 and 3 and Are Negative for Claudin 4.
Shousha S, Anscombe O, McFarlane T., Free PMC Article | 04/3/2021 |
| Role of Nuclear Claudin-4 in Renal Cell Carcinoma. | Role of Nuclear Claudin-4 in Renal Cell Carcinoma.
Owari T, Sasaki T, Fujii K, Fujiwara-Tani R, Kishi S, Mori S, Mori T, Goto K, Kawahara I, Nakai Y, Miyake M, Luo Y, Tanaka N, Kondoh M, Fujimoto K, Kuniyasu H., Free PMC Article | 03/20/2021 |
| Claudin-4 shows superior specificity for mesothelioma vs non-small-cell lung carcinoma compared with MOC-31 and Ber-EP4. | Claudin-4 shows superior specificity for mesothelioma vs non-small-cell lung carcinoma compared with MOC-31 and Ber-EP4.
Naso JR, Churg A. | 10/31/2020 |
| Targeting claudin-4 enhances chemosensitivity of pancreatic ductal carcinomas. | Targeting claudin-4 enhances chemosensitivity of pancreatic ductal carcinomas.
Sasaki T, Fujiwara-Tani R, Kishi S, Mori S, Luo Y, Ohmori H, Kawahara I, Goto K, Nishiguchi Y, Mori T, Sho M, Kondo M, Kuniyasu H., Free PMC Article | 08/29/2020 |
| Claudin-4 immunohistochemistry is a useful pan-carcinoma marker for serous effusion specimens. | Claudin-4 immunohistochemistry is a useful pan-carcinoma marker for serous effusion specimens.
Vojtek M, Walsh MD, Papadimos DJ, Shield PW. | 08/22/2020 |
| in Basaloid squamous cell carcinomas , SOX2 and PCNA had diffuse staining patterns in almost all cancer cells. SOX2 overexpression had little effect on the expression levels of claudin4, occludin and PCNA | Differential expression of claudin‑4, occludin, SOX2 and proliferating cell nuclear antigen between basaloid squamous cell carcinoma and squamous cell carcinoma.
Sato F, Bhawal UK, Tojyo I, Fujita S, Murata SI, Muragaki Y. | 12/28/2019 |